Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
SIRNAOMICS-B (02257) completes issuance of 2.5 million new shares.
Middle East conflict pushes up oil prices, South Korea considers implementing a cap on oil prices for the first time in 30 years.
LAPLACE Renewable Energy Technology (688726.SH) shareholders plan to collectively reduce their holdings by no more than 1% of the shares.
SIRNAOMICS-B (02257) completes issuance of 2.5 million new shares.
Middle East conflict pushes up oil prices, South Korea considers implementing a cap on oil prices for the first time in 30 years.
LAPLACE Renewable Energy Technology (688726.SH) shareholders plan to collectively reduce their holdings by no more than 1% of the shares.
RECOMMEND
